COMMUNIQUÉS West-GlobeNewswire

Fagron NV: Waterland and Baltisse announce private placement of shares in Fagron
02/07/2019
Regulated information - Inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 2 July 2019 – 16:45 CEST Waterland and Baltisse announce private placement of shares in Fagron Fagron NV (“Fagron”) has been [...]
Ludlow Research Initiates Coverage on BioHemp International (BKIT) Based on CBD Distribution Business Model And Assigns A Short Term 'Speculative' Price Target Per Share of $2.50 -$3.50
02/07/2019
NEW YORK, July 02, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- BioHemp International, Inc. (OTC: BKIT), (“Company”) announces a research opinion on the company is now available for download. Report Highlights - To [...]
Generex Engages Donohoe Advisory to Assist with Uplisting
02/07/2019
MIRAMAR, Fla., July 02, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that Generex has engaged Donohoe [...]
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance
02/07/2019
Top-line Data Readout Remains on Track for early Q4 2019 LOS ANGELES, July 02, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative [...]
Surya Psychiatric Clinic Brings Revolutionary FDA-Cleared Mental Health Technology for Major Depressive Disorder (MDD) to Patients in Arizona
02/07/2019
Patients in Tucson and beyond are now able to sign up for treatment with cutting-edge Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for MDD TUCSON, Ariz., July 02, 2019 (GLOBE NEWSWIRE) -- Surya Psychiatric [...]
Vaccex, Inc. Introductory Press Release
02/07/2019
BOSTON, July 02, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Vaccex, Inc. a Boston, Massachusetts-based biotechnology company that is focused on developing and commercializing immunotherapy products for the treatment of [...]
Medtronic Announces Closing of Public Offering of €5 Billion of Senior Notes
02/07/2019
DUBLIN, July 02, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (the “Company”) (NYSE:MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. (“Medtronic Luxco”) has closed a registered public [...]
Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery
02/07/2019
CALGARY, Alberta, July 02, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company developing and commercializing blood-derived stem cell [...]
Humanigen Secures Exclusive Worldwide License to Gene-Editing Technology from Mayo Clinic to Improve CAR-T
02/07/2019
Expands Humanigen’s intellectual property portfolio to include gene-edited CAR-T cells Builds and further strengthens Humanigen’s leadership position in GM-CSF neutralization GM-CSF neutralization has the potential to [...]
Agritek Holdings, Inc. Announces Letter of Intent to Acquire Colorado Manufacturing License and Established Vape Brand as New State Legislation Allows Public Company Investment and Acquisitions
02/07/2019
LOS ANGELES, CA, July 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and [...]
World Chocolate Day Dilemma Solved With Umbrellux DAO
02/07/2019
ANN ARBOR, Mich., July 02, 2019 (GLOBE NEWSWIRE) -- Chocolate will be celebrated around the globe on July 7 during World Chocolate Day. Often noted for its mood-boosting chemical effect to the brain, a lesser known fact [...]
Third Clinical Site Initiated for BrainStorm Cell Therapeutic’s Phase 2 Progressive MS Study
02/07/2019
NEW YORK, July 02, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( NASDAQ: BCLI ), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, [...]
TRACON Pharmaceuticals Provides Update on Phase 1/2 Trial of TRC253 in Patients with Metastatic Castrate Resistant Prostate Cancer
02/07/2019
Phase 1 Data Published in ASCO Proceedings Determined the Recommended Phase 2 Dose Additional Cohort of Patients with a Specific Androgen Receptor Point Mutation Added to Ongoing Phase 2 Study Phase 2 Data Expected in 2 [...]
Cybrexa Therapeutics Receives SBIR Grant to Support Development of Lead Candidate CBX-11 in Combination with Chemotherapy Agents
02/07/2019
NEW HAVEN, Conn., July 02, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced that the [...]
Grace Colón succeeds Amy Abernethy on the CareDx Board
02/07/2019
Colón brings expertise to grow patient centric innovation capabilities at CareDx BRISBANE, Calif., July 02, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the [...]
Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with Pfizer’s CDK4/6 Inhibitor Palbociclib
02/07/2019
Study is part of clinical trial collaboration with Pfizer SOUTH SAN FRANCISCO, Calif., July 02, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on [...]
Intra-Cellular Therapies Appoints Karen Patruno Sheehy, Esq. as Senior Vice President, Chief Compliance Officer
02/07/2019
NEW YORK, July 02, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Ovid Therapeutics Receives Orphan Drug Designation from the European Commission for OV101 for the Treatment of Angelman Syndrome
02/07/2019
NEW YORK, July 02, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
Quotient Board Announces Contract Extension of CEO Franz Walt
02/07/2019
JERSEY, Channel Islands, July 02, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced the Board of [...]

Pages